Clinical trials
Withdrawn Observational trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 14 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 84 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Fudan University | 6 |
| Westlake University | 6 |
| Shandong University | 4 |
| West China Hospital | 4 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 3 |
| Sun Yat-sen University | 3 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 3 |
| Peking University First Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Takeda | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 4 |
| Cardiovascular Diseases | 3 |
| Critical Illness | 3 |
| Lung Neoplasms | 3 |
| Purpura, Thrombocytopenic, Idiopathic | 3 |
| COVID-19 | 2 |
| Cognitive Dysfunction | 2 |
| Diabetes Mellitus | 2 |
| Disease | 2 |
| Enterocolitis, Necrotizing | 2 |
Trials
Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.